Brief: Bone Therapeutics And Catalent Sign Agreements To Streamline ALLOB Production

Biosenic SA

29/10/2020 06:13

Oct 29 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * BONE THERAPEUTICS AND CATALENT SIGN AGREEMENTS TO
STREAMLINE
PRODUCTION OF THE ALLOGENEIC CELL THERAPY PRODUCT, ALLOB
    * CATALENT TO ACQUIRE BONE THERAPEUTICS' CELL THERAPY
MANUFACTURING FACILITY FOR EUR 12 MLN
    * BONE THERAPEUTICS AND CATALENT SHALL ENTER INTO A SUPPLY
AGREEMENT FOR FURTHER DEVELOPMENT OF ALLOB
    * TRANSACTION IS EXPECTED TO CLOSE IN NOVEMBER 2020

Source text for Eikon:  ID:nGNE6Fjb0P 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))